Compare STXS & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | LFMD |
|---|---|---|
| Founded | 1990 | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 190.9M |
| IPO Year | 2004 | N/A |
| Metric | STXS | LFMD |
|---|---|---|
| Price | $1.89 | $3.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $4.00 | ★ $9.14 |
| AVG Volume (30 Days) | 404.0K | ★ 1.3M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,346,617.00 | N/A |
| Revenue This Year | $34.08 | $16.11 |
| Revenue Next Year | $35.18 | $20.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.54 | $2.60 |
| 52 Week High | $3.59 | $15.34 |
| Indicator | STXS | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 46.05 |
| Support Level | $1.74 | $3.43 |
| Resistance Level | $1.95 | $4.19 |
| Average True Range (ATR) | 0.09 | 0.26 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 56.52 | 6.82 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.